2022 Medicinal Chemistry Reviews, pages 447-471

THE RISE, FALL, AND FUTURE PROMISE OF IDO1 INHIBITORS FOR IMMUNO-ONCOLOGY

Emily C Cherney 1
, 
DAVID K. WILLIAMS 1
, 
Liping Zhang 1
, 
Susheel J Nara 2
1
 
Bristol Myers Squibb, Lawrenceville, New Jersey, U.S.A. | 
2
 
Biocon BMS R&D Center, Bengaluru, India | 
Publication type: Book Chapter
Publication date: 2023-11-16
SJR: —
CiteScore: —
Impact factor: —
ISSN: 25759183, 25759175
Found 

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Share
Cite this
GOST | RIS | BibTex
Found error?